Helena Elding Larsson
61 – 70 of 158
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Motifs of Three HLA-DQ Amino Acid Residues (α44, β57, β135) Capture Full Association With the Risk of Type 1 Diabetes in DQ2 and DQ8 Children
- Contribution to journal › Article
-
Mark
Distinct growth phases in early life associated with the risk of type 1 diabetes : The teddy study
- Contribution to journal › Article
-
Mark
One-Hour Oral Glucose Tolerance Tests for the Prediction and Diagnostic Surveillance of Type 1 Diabetes
- Contribution to journal › Article
- 2019
-
Mark
Reduced display of conformational epitopes in the N-terminal truncated GAD65 isoform : relevance for people with stiff person syndrome or DQ8/8-positive Type 1 diabetes mellitus
- Contribution to journal › Article
-
Mark
Effect of screening for type 1 diabetes on early metabolic control : the DiPiS study
- Contribution to journal › Article
-
Mark
Eleven Amino Acids of HLA-DRB1 and Fifteen Amino Acids of HLA-DRB3, 4 and 5 Include Potentially "Causal Residues" Responsible for the Risk of Childhood Type 1 Diabetes
- Contribution to journal › Article
-
Mark
Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials—GPPAD-02 study design and first results
- Contribution to journal › Article
-
Mark
Autoantibodies in Pandemrix®-induced narcolepsy : Nine candidate autoantigens fail the conformational autoantibody test
- Contribution to journal › Article
-
Mark
Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk : The GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol
- Contribution to journal › Article
-
Mark
Screening for asymptomatic β-cell autoimmunity in young children
- Contribution to journal › Debate/Note/Editorial
